Brown & Brown Inc., a prominent player in the financial sector, specifically within the insurance industry, has recently been the subject of analysis by JP Morgan. The company, which is publicly traded on the New York Stock Exchange, offers a comprehensive suite of insurance and reinsurance products and services. In addition to these offerings, Brown & Brown Inc. provides risk management, employee benefit administration, and managed health care services. The company maintains a widespread presence across the United States and can be accessed through its website at www.bbinsurance.com .
As of December 21, 2025, the closing price of Brown & Brown Inc.’s stock was $80.37. Over the past year, the stock has experienced significant volatility, with a 52-week high of $125.68 on April 2, 2025, and a 52-week low of $76.17 on November 5, 2025. This range indicates a notable decline from its peak value earlier in the year.
The company’s market capitalization stands at approximately $27.38 billion USD, reflecting its substantial presence in the market. Key valuation metrics reveal a price-to-earnings (P/E) ratio of 24.32 and a price-to-book (P/B) ratio of 2.21. These figures suggest that the market values Brown & Brown Inc. at about 24 times its earnings and 2.2 times its book value. Such multiples are above average, indicating a strong market perception of the company’s earnings potential and asset base.
In a recent development, JP Morgan initiated coverage of Brown & Brown Inc.’s stock on December 18, 2025, assigning it a neutral rating. This assessment by a major financial institution underscores the company’s strategic position within the insurance sector, despite the recent fluctuations in its stock price.
As of the latest update, Brown & Brown Inc. has not released any new public disclosures. Investors and stakeholders are likely to monitor the company’s performance closely, particularly in light of the recent analysis by JP Morgan and the ongoing market dynamics.
